Markku Partinen

Person

Latest publications

  1. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia

    Lähteenmäki, R., Neuvonen, P. J., Puustinen, J., Vahlberg, T., Partinen, M., Räihä, I. & Kivelä, S-L., Mar 2019, In : Basic & Clinical Pharmacology & Toxicology. 124, 3, p. 330-340 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Solriamfetol for the Treatment of Excessive Sleepiness in OSA A Placebo-Controlled Randomized Withdrawal Study

    Tones 4 Study Investigators, Strollo, P. J., Hedner, J., Partinen, M., Polo, O. & Saaresranta, T., Feb 2019, In : Chest. 155, 2, p. 364-374 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy

    Luo, G., Ambati, A., Lin, L., Bonvalet, M., Partinen, M., Ji, X., Maecker, H. T. & Mignot, E. J-M., 26 Dec 2018, In : Proceedings of the National Academy of Sciences of the United States of America. 115, 52, p. E12323-E12332 10 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (164) »

Latest activities

  1. European Narcolepsy Network (External organisation)

    Markku Partinen (Chair)
    2014 → …

    Activity: Membership typesMembership or other role in national/international committee, council, board

  2. European Narcolepsy Network (External organisation)

    Markku Partinen (Chair)
    2014 → …

    Activity: Membership typesMembership or other role in national/international committee, council, board

View all (2) »

ID: 126453